Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Envista Holdings CorpNVST · Entity 4007 | Director | May 19, 2026 | May 21, 2026 |
| ICU MEDICAL INC/DEICUI · Entity 2385 | Director · Chairman and CEO | March 15, 2026 | March 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Envista Holdings Corp
Report date May 19, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 52,945 |
Reported balance
After 2026-05-19 transaction · row 1
1 source rowRow 1 · 2026-05-19 · Grant · Acquired 9,330 · Balance 52,945 F1: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.
ICU MEDICAL INC/DE
Report date March 15, 2026 · Filed March 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 134,106 |
Reported balance
After 2026-03-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-15 · Exercise / conversion · Acquired 17,100 · Balance 134,106 F1: These Securities are Performance-based Restricted Stock Units (PRSU). F2: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein. |
| Common StockSEC Table I · non-derivative | Direct | 124,654 |
Reported balance
After 2026-03-15 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-03-15 · Tax withholding · Disposed 9,452 · Balance 124,654 F1: These Securities are Performance-based Restricted Stock Units (PRSU). |
| Common StockSEC Table I · non-derivative | Direct | 129,526 |
Reported balance
After 2026-03-15 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-03-15 · Exercise / conversion · Acquired 4,872 · Balance 129,526 F3: These securities are Restricted Stock Units. |
| Common StockSEC Table I · non-derivative | Direct | 126,833 |
Reported balance
After 2026-03-15 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-03-15 · Tax withholding · Disposed 2,693 · Balance 126,833 F3: These securities are Restricted Stock Units. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-03-15 | Direct | 0 |
Reported balance
After 2026-03-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-03-15 · Exercise / conversion · Disposed 4,872 · Balance 0 F3: These securities are Restricted Stock Units. F4: There is neither a purchase price nor an exercise price for the Restricted Stock Units. |
| Performance SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-03-15 | Direct | 0 |
Reported balance
After 2026-03-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-03-15 · Exercise / conversion · Disposed 17,100 · Balance 0 F1: These Securities are Performance-based Restricted Stock Units (PRSU). F5: There is neither a purchase price nor an exercise price for the PRSUs. F2: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein. |
| Common StockSEC Table I · non-derivative | Indirectby Trust | 152,339 |
Reported balance
Holding disclosure · report date 2026-03-15 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 152,339 |
Filing footnotes · ownership attribution and instrument terms
F1: These Securities are Performance-based Restricted Stock Units (PRSU).
F2: Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein.
F3: These securities are Restricted Stock Units.
F4: There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F5: There is neither a purchase price nor an exercise price for the PRSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 1,699 | $190.48 | $323,628.92 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · nonDerivative · entry 12 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,677 F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.16 to $191.12, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,699 | $58.79 | $99,884.21 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · nonDerivative · entry 11 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,376 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 785 | $189.32 | $148,613.61 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · nonDerivative · entry 10 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,677 F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.06 to $189.89, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 785 | $58.79 | $46,150.15 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · nonDerivative · entry 9 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 8,163 | $188.52 | $1,538,852.03 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · nonDerivative · entry 8 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,677 F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.06 to $189.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 8,163 | $58.79 | $479,902.77 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · nonDerivative · entry 7 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,840 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 2,781 | $187.43 | $521,253.95 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · nonDerivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,677 F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $187.05 to $188.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,781 | $58.79 | $163,494.99 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · nonDerivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 3,637 | $186.50 | $678,311.05 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,677 F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.05 to $187.04, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 3,637 | $58.79 | $213,819.23 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 6,712 | $185.73 | $1,246,623.12 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,677 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.04 to $186.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 14, 2023 Filed Jun 15, 2023 14:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 6,712 | $58.79 | $394,598.48 |
DisclosureSEC source: 0001410442-23-000004 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,389 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises/sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 15, 2023. Read SEC document |
| June 02, 2023 Filed Jun 5, 2023 15:13 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GiftCommon Stock | 85 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-23-000003 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,677 F1 · price: This was a bona fide gift with no payment in consideration Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:35 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantCommon Stock | 5,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-23-000046 · wf-form4_168504689173212.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,080 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| May 17, 2023 Filed May 18, 2023 17:21 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 14,615 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-23-000002 · edgardoc.xml · derivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,615 Underlying: Common Stock · 14,615 shares Expires 2026-03-15 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. These awards were legally granted on March 15, 2023 but were subject to shareholder approval on May 17, 2023. Read SEC document |
| March 08, 2023 Filed Mar 8, 2023 21:56 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 2,525 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-23-000001 · edgardoc.xml · derivative · entry 11 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,525 Underlying: Common Stock · 2,525 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 08, 2023 Filed Mar 8, 2023 21:56 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,329 | $156.17 | $207,549.93 |
DisclosureSEC source: 0001410442-23-000001 · edgardoc.xml · nonDerivative · entry 8 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,762 Read SEC document |
| March 08, 2023 Filed Mar 8, 2023 21:56 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-23-000001 · edgardoc.xml · nonDerivative · entry 7 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:56 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 3,218 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-23-000001 · edgardoc.xml · derivative · entry 12 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,436 Underlying: Common Stock · 3,218 shares Expires 2025-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:56 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,694 | $157.47 | $266,754.18 |
DisclosureSEC source: 0001410442-23-000001 · edgardoc.xml · nonDerivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,566 Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:56 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 3,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-23-000001 · edgardoc.xml · nonDerivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:56 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 9,994 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-23-000001 · edgardoc.xml · derivative · entry 13 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,994 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F7 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F8 · derivative.exercise_date: These PRSUs were granted on March 6, 2020 and were subject to the satisfaction of both performance-based and time-based criteria. These PRSUs had a 3-year performance period and cliff-vested on the third anniversary of the grant date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:56 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,773 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-23-000001 · edgardoc.xml · derivative · entry 10 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,773 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:56 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 5,261 | $161.25 | $848,336.25 |
DisclosureSEC source: 0001410442-23-000001 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,042 Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:56 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 9,994 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-23-000001 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:56 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 933 | $161.25 | $150,446.25 |
DisclosureSEC source: 0001410442-23-000001 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,309 Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:56 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,773 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-23-000001 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| May 24, 2022 Filed May 31, 2022 20:32 UTC | Envista Holdings Corp NVST · Entity 4007 | GrantCommon Stock | 4,435 | $0.00 | $0.00 |
DisclosureSEC source: 0001757073-22-000077 · wf-form4_165402914784724.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,655 F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest one year after the grant date. RSUs are payable in shares of common stock on a one-to-one basis. Read SEC document |
| May 23, 2022 Filed May 23, 2022 20:42 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GiftCommon Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-22-000003 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,469 F1 · price: This was a bona fide gift with no payment in consideration Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 00:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 2,524 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-22-000002 · edgardoc.xml · derivative · entry 9 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,050 Underlying: Common Stock · 2,524 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 00:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 1,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-22-000002 · edgardoc.xml · nonDerivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,499 Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 00:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 2,524 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-22-000002 · edgardoc.xml · nonDerivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,827 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 00:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 9,654 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-22-000002 · edgardoc.xml · derivative · entry 10 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,654 Underlying: Common Stock · 9,654 shares Expires 2025-03-07 F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 06, 2022 Filed Mar 9, 2022 00:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-22-000002 · edgardoc.xml · derivative · entry 11 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,444 shares Expires 2022-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 06, 2022 Filed Mar 9, 2022 00:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,772 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-22-000002 · edgardoc.xml · derivative · entry 8 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,773 Underlying: Common Stock · 1,772 shares Expires 2023-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 06, 2022 Filed Mar 9, 2022 00:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 760 | $242.93 | $184,626.80 |
DisclosureSEC source: 0001410442-22-000002 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,303 Read SEC document |
| March 06, 2022 Filed Mar 9, 2022 00:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-22-000002 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 06, 2022 Filed Mar 9, 2022 00:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 932 | $242.93 | $226,410.76 |
DisclosureSEC source: 0001410442-22-000002 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,619 Read SEC document |
| March 06, 2022 Filed Mar 9, 2022 00:11 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,772 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-22-000002 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,551 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2022 Filed Mar 5, 2022 00:48 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 36,000 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-22-000001 · edgardoc.xml · derivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,366 Underlying: Common Stock · 36,000 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. Read SEC document |
| March 03, 2022 Filed Mar 5, 2022 00:48 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 36,000 | $240.00 | $8,640,000.00 |
DisclosureSEC source: 0001410442-22-000001 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,779 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| March 03, 2022 Filed Mar 5, 2022 00:48 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 36,000 | $58.79 | $2,116,440.00 |
DisclosureSEC source: 0001410442-22-000001 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. Read SEC document |
| December 30, 2021 Filed Dec 30, 2021 21:59 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,159 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-21-000010 · edgardoc.xml · derivative · entry 10 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,366 Underlying: Common Stock · 1,159 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. Read SEC document |
| December 30, 2021 Filed Dec 30, 2021 21:59 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 1,159 | $240.00 | $278,160.00 |
DisclosureSEC source: 0001410442-21-000010 · edgardoc.xml · nonDerivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,779 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| December 30, 2021 Filed Dec 30, 2021 21:59 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,159 | $58.79 | $68,137.61 |
DisclosureSEC source: 0001410442-21-000010 · edgardoc.xml · nonDerivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. Read SEC document |
| December 29, 2021 Filed Dec 30, 2021 21:59 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,677 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-21-000010 · edgardoc.xml · derivative · entry 9 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,525 Underlying: Common Stock · 10,677 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. Read SEC document |
| December 29, 2021 Filed Dec 30, 2021 21:59 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 10,677 | $240.00 | $2,562,492.81 |
DisclosureSEC source: 0001410442-21-000010 · edgardoc.xml · nonDerivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,779 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.00 to $240.07, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 29, 2021 Filed Dec 30, 2021 21:59 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 10,677 | $58.79 | $627,700.83 |
DisclosureSEC source: 0001410442-21-000010 · edgardoc.xml · nonDerivative · entry 3 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 21:59 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 164 | $0.00 Strike: $58.79 | $0.00 |
DisclosureSEC source: 0001410442-21-000010 · edgardoc.xml · derivative · entry 8 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,202 Underlying: Common Stock · 164 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 21:59 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 164 | $240.00 | $39,360.00 |
DisclosureSEC source: 0001410442-21-000010 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,779 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.